A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy – including photon and proton therapy – for the treatment of radioresistant tumors: the ETOILE trial

Peer Review reports

Original Submission
29 Mar 2022	Submitted	Original manuscript
12 Apr 2022	Author responded	Author comments - Jacques Balosso
Resubmission - Version 2
12 Apr 2022	Submitted	Manuscript version 2
Publishing
17 Apr 2022	Editorially accepted
23 May 2022	Article published	10.1186/s12885-022-09564-7

Back to article page